- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 489-503 of
1,261 results
1079 Exhibit: 1079 NCT00167115, CLINICALTRIALSGOV, httpswwwclinicaltrialsgo...
Document
IPR2024-00631, No. 1079 Exhibit - 1079 NCT00167115, CLINICALTRIALSGOV, httpswwwclinicaltrialsgovct2sh (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1049 Exhibit: 1049 International Conference on Harmonisation Dose Response Info...
Document
IPR2024-00631, No. 1049 Exhibit - 1049 International Conference on Harmonisation Dose Response Information t (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1020 Exhibit: 1020 Bydureon prescribing information Jan 2012
Document
IPR2024-00631, No. 1020 Exhibit - 1020 Bydureon prescribing information Jan 2012 (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1007 Exhibit: 1007 Declaration of Paul Dalby, PhD
Document
IPR2024-00631, No. 1007 Exhibit - 1007 Declaration of Paul Dalby, PhD (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1004 Exhibit: CV of John Bantle, MD
Document
IPR2024-00631, No. 1004 Exhibit - CV of John Bantle, MD (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1062 Exhibit: 1062 Zarin, The ClinicalTrialsgov Results Database—Update and Key I...
Document
IPR2024-00631, No. 1062 Exhibit - 1062 Zarin, The ClinicalTrialsgov Results Database—Update and Key Issues, (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1067 Exhibit: 1067 US Patent No 8,536,122
Document
IPR2024-00631, No. 1067 Exhibit - 1067 US Patent No 8,536,122 (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
2011 Exhibit: EX2011 Patent Exclusivity for N209637 SemaglutideOzempic, Orang...
Document
IPR2024-00631, No. 2011 Exhibit - EX2011 Patent Exclusivity for N209637 SemaglutideOzempic, Orange Book Approved Drug Products with Therapeutic Equivalence Evaluations, US Food D...
|
|
Cite Document
2003 Exhibit: EX2003 June 7, 2024 Joint Stipulation to Modify Due Dates 3, 4, 5, 6,...
Document
IPR2024-00631, No. 2003 Exhibit - EX2003 June 7, 2024 Joint Stipulation to Modify Due Dates 3, 4, 5, 6, 7 and 8, Mylan Pharms Inc v Novo Nordisk AS, IPR2023 00724, Paper 56 (P.T.A.B. Jun...
|
|
Cite Document
2008 Exhibit: EX2008 Excerpted Declaration of Christopher A Vellturo, PhD, Mylan...
Document
IPR2024-00631, No. 2008 Exhibit - EX2008 Excerpted Declaration of Christopher A Vellturo, PhD, Mylan Pharms Inc v Novo Nordisk AS, IPR2023 00724, EX2300 (P.T.A.B. Jun. 12, 2024)
|
|
Cite Document
1034 Exhibit: 1034 US Patent No 6,268,343
Document
IPR2024-00631, No. 1034 Exhibit - 1034 US Patent No 6,268,343 (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1033 Exhibit: 1033 Knudsen, Liraglutide, a GLP1 Analogue to Treat Diabetes, in A...
Document
IPR2024-00631, No. 1033 Exhibit - 1033 Knudsen, Liraglutide, a GLP1 Analogue to Treat Diabetes, in ANALOGUE (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1057 Exhibit: 1057 WO 2011073328
Document
IPR2024-00631, No. 1057 Exhibit - 1057 WO 2011073328 (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1056 Exhibit: 1056 US Patent No 5,118,666
Document
IPR2024-00631, No. 1056 Exhibit - 1056 US Patent No 5,118,666 (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
1040 Exhibit: 1040 Vilsbøll, Glucagon Like Peptide 1 and Diabetes Treatment, 21 IN...
Document
IPR2024-00631, No. 1040 Exhibit - 1040 Vilsbøll, Glucagon Like Peptide 1 and Diabetes Treatment, 21 INT’L DIA (P.T.A.B. Mar. 1, 2024)
|
|
Cite Document
